VanEck Pharmaceutical ETF
PPH
PPH
58 hedge funds and large institutions have $108M invested in VanEck Pharmaceutical ETF in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $121M → $108M (-$13.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.9M | |
| 2 | +$2.54M | |
| 3 | +$2.35M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.24M |
| 5 |
SG Americas Securities
New York
|
+$1.88M |
Top Sellers
| 1 | -$18.8M | |
| 2 | -$15.8M | |
| 3 | -$7.39M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.11M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$1.12M |